|
MGAT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.093400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.443020E-01 |
| Normal-vs-Stage2 |
3.126600E-01 |
| Normal-vs-Stage3 |
7.643400E-01 |
| Normal-vs-Stage4 |
6.479600E-01 |
| Stage1-vs-Stage2 |
8.681800E-01 |
| Stage1-vs-Stage3 |
2.819500E-02 |
| Stage1-vs-Stage4 |
5.551600E-02 |
| Stage2-vs-Stage3 |
2.017800E-01 |
| Stage2-vs-Stage4 |
1.824760E-01 |
| Stage3-vs-Stage4 |
8.498800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.226800E-01 |
| Normal-vs-AfricanAmerican |
7.659600E-01 |
| Normal-vs-Asian |
5.757000E-01 |
| Caucasian-vs-AfricanAmerican |
6.917600E-01 |
| Caucasian-vs-Asian |
7.769800E-01 |
| AfricanAmerican-vs-Asian |
8.695400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.323200E-01 |
| Normal-vs-Female |
2.683800E-01 |
| Male-vs-Female |
2.294400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.286300E-02 |
| Normal-vs-Age(41-60Yrs) |
9.765000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.041400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.301200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.289700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.322400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.103600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.268000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.830400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.738000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.891240E-01 |
| Classical-VS-Follicular |
2.701800E-02 |
| Classical-VS-Other |
7.562200E-01 |
| Classical-VS-Normal |
1.174010E-01 |
| Tall-VS-Follicular |
8.956200E-01 |
| Tall-VS-Other |
7.383400E-01 |
| Tall-VS-Normal |
9.465000E-01 |
| Follicular-VS-Other |
7.014000E-01 |
| Follicular-VS-Normal |
7.994400E-01 |
| Other-VS-Normal |
7.316800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.035600E-01 |
| Normal-vs-N1 |
5.830200E-01 |
| N0-vs-N1 |
2.474800E-01 |
|
|
